During the past decade, Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o." #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o." are "Atopic Dermatitis" (3 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o." are "Biological" (3 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (3 trials), "BMS-986165" (2 trials), "Placebo" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".